Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.38 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28772606 | 1.00 | DPP4 (0.48) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL3511627 | 1.00 | DPP4 (0.48) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL20312145 | 0.76 | CYP1A2 (0.52) | DPP4F2HTR2ALMNA | |
| SCHEMBL8007285 | 0.76 | HTR2A (0.41) | DPP4F2HTR2ALMNA | |
| SCHEMBL7366231 | 0.74 | ALDH1A1 (0.39) | DPP4F2HTR2ATAAR1LMNA | |
| SCHEMBL1036921 | 0.72 | DPP4 (0.50) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL6963122 | 0.72 | DPP4 (0.50) | DPP4F2HTR2ATAAR1ADRA2A | |
| SCHEMBL9804450 | 0.72 | ALDH1A1 (0.43) | DPP4F2HTR2ATAAR1LMNA | |
| SCHEMBL6048471 | 0.72 | ALDH1A1 (0.43) | DPP4F2HTR2ALMNA | |
| SCHEMBL7572963 | 0.72 | HTR2A (0.48) | HTR2ATAAR1ADRA2AADRA2CLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111978151-B | Preparation method of 3-methyl-2-butenol | 山东新和成药业有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-111978151-A | Preparation method of 3-methyl-2-butenol | 山东新和成药业有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-111978151-B | Preparation method of 3-methyl-2-butenol | 山东新和成药业有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-111978151-A | Preparation method of 3-methyl-2-butenol | 山东新和成药业有限公司 | 2020-11-24 | — | — | CN | disclosed |
| US-10597366-B2 | Aryl ethers and uses thereof | PELOTON THERAPEUTICS, INC. (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190119214-A1 | ARYL ETHERS AND USES THEREOF | PELOTON THERAPEUTICS, INC. | 2019-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190119214-A1 | ARYL ETHERS AND USES THEREOF | HIF1AN, EGLN2, VHL | DPP4 3278/4885F2 4436/4885HTR2A 1798/4885 |
| US-10597366-B2 | Aryl ethers and uses thereof | HIF1AN, EGLN2, VHL | DPP4 3278/4885F2 4436/4885HTR2A 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.